Podcasts about facofp

Dr. Lori Boyajian-O'Neill, D.O., FAOASM, FACOFP, a concussion specialist, joins Bryce Hamilton, LCSW to address common myths and questions about concussions. Dr. Lori emphasizes how parents can help set boundaries for keeping their kids safe, especially on team sports. She lays out the differences between a concussion and CTE. Together they discuss how to help […] The post Caring for Children with CTE and Concussions Pt. II With Dr. Lori appeared first on WebTalkRadio.net.

Episode: October 2024, with Special Guest Dr. Kate Galluzzi on Utilization of Telemedicine to Supervise Medical Students in the PALTC Setting Host: Karl Steinberg, MD, HMDC, CMD Guest(s): Katherine E. Galluzzi, DO, CMD, FACOFP *dist.*; Barbara Resnick, PhD, CRNP (Co-Editor-in-Chief, JAMDA) In This Episode: In this episode, host Dr. Karl Steinberg, MD, CMD, and co-editor-in-chief Dr. Barb Resnick, PhD, CRNP, will talk with Dr. Galluzzi about her focus on utilization of telemedicine to supervise medical students in the post-acute and long-term care setting. In addition to Dr. Galluzzi's paper, Drs. Steinberg and Resnick will review three additional articles.  Articles Referenced: Utilization of Telemedicine to Supervise Medical Students in the Post-Acute/Long-Term Care Setting Understanding the Perspectives of Key Stakeholders toward Medicare's Home Health Value-Based Purchasing (HHVBP) in the US Paramedic-Assisted Community Evaluation After Discharge: The PACED Intervention A Cluster Randomized Trial: Mixed Methods Comparison of 2 Approaches to Promote Nonpharmacologic, Resident-Centered Dementia Care in Nursing Homes Date Recorded: October 21, 2024 Available Credit: The American Board of Post-Acute and Long-Term Care Medicine (ABPLM) issues CMD credits for select PALTtalk podcast episodes as follows: Claim CMD Credit

Bryce Hamilton, LCSW sits down with Dr. Lori Boyajian-O'Neill, D.O., FAOASM, FACOFP a concussion specialist practicing in the Kansas City area. Dr. Lori shares her expertise on recognizing and treating concussions, focusing on the risk and treatment of concussions in children, teens and young athletes. She discusses how to advocate for our children and teens […] The post Concussions 101 with Dr. Lori appeared first on WebTalkRadio.net.

‘…how can this happen in the United States of America!!!' In this week Neil interviews Katarina Lindley, D.O. FACOFP - together they discuss health, medicine, ethics & putting the world to rights. To help support this podcast & get extra, exclusive content every week sign up to Neil Oliver on Patreon.comhttps://www.patreon.com/neiloliver Neil Oliver Website:https://www.neiloliver.com Neil Oliver Shop - check out my t-shirts, mugs & other channel merchandise:https://neil-oliver.creator-spring.com Neil Oliver Instagram - NeilOliverLoveLetter:https://www.instagram.com/neiloliverloveletter Neil Oliver Podcasts:Season 1: Neil Oliver's Love Letter To The British IslesSeason 2: Neil Oliver's Love Letter To The WorldAvailable on all the usual providershttps://podcasts.apple.com/gb/podcast/neil-olivers-love-letter-to-the-british-isles Hosted on Acast. See acast.com/privacy for more information.

Dr. Rob Kominiarek D.O., FACOFP is a board certified Fellow of the American College of Osteopathic Family Physicians and a Fellows Crest Award Winner with advanced training in Age Management Medicine and Hormone Optimization. He is president and medical director of ReNue Health®. Dr. Rob is a graduate of the Nova-Southeastern University, College of Osteopathic Medicine in Fort Lauderdale, Florida. He completed his residency training at Ohio University, Grandview Hospital and Medical Center in Dayton, Ohio and is an Assistant Clinical Professor at Ohio University. An Amazon Bestselling Author. Dr. Rob is a veteran of the United States Army and is a bestselling author with a passion directed towards overall health of the mind and body thru proper nutritional habits, regular exercise, appropriate supplementation, and the intelligent optimization of hormones.Dr. Rob is a commercial type rated pilot currently flying a Baron 58P and enjoys cycling, swimming, soccer, tennis, soaring, skiing Utah, Italian motorcycles, and automobile racing. Dr. Rob is a dedicated father who believes in practicing what he preaches, and as such lives a lifestyle dedicated towards healthy living and regular exercise.Have a question you want us to answer live? ASK HERETo connect with Liz Roman click HERETo connect with Becca Chilczenkowski click HEREThis episode is brought to you by FITMOMFollow us on YouTubeLooking for high quality, theraputic grade supplements? If so, join our practitioner portal, Fullscript, and purchase quality supplements 15% off!Our favorite nontoxic skincare is FRE Skincare. Their breakthrough dual action formula that fights breakouts and the signs of aging with high impact natural ingredients. Use code LIZROMAN at checkout!Get a FREE Sample pack of LMNT! LMNT is a electrolyte drink mix that is formulated to help anyone with their electrolyte needs and is perfectly suited to folks following a keto, low-carb, or paleo diet AND it is soo tasty - great for flavoring water and helping you drink more!Produced by brandhard

Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)What is lipedema, and what can be done to address it?This week, we explore lipedema, a condition characterized by abnormal fat build up in regions like the legs and arms, leading to swelling, pain, and tenderness. It predominantly affects women and is believed to have a genetic component. Unlike typical weight gain, fat associated with lipedema is stubborn to respond to diet and exercise. Treatment options encompass compression therapy, physical therapy, and, in some instances, surgical intervention.Joining us is Dr. Nicholas Pennings, a distinguished figure in the field. Dr. Pennings serves as an associate professor of family medicine at Campbell University and is a board-certified physician specializing in obesity medicine. He has contributed to establishing standards of care for lipedema in the U.S. and continues to impart knowledge to healthcare professionals through his affiliation with the Obesity Medicine AssociationWe also dove into crucial topics including:Challenges in Conventional Weight Loss Interventions for LipedemaUnderstanding and TreatmentPrevalence of LipedemaIf you're seeking deeper insights into lipedema, don't miss out on this episode. Dr. Pennings' expertise on this condition is truly invaluable and can offer tremendous help to those grappling with it!Connect with Dr. Pennings:LinkedIn: Nicholas Pennings, DO, FOMA, FACOFP, FAAFPConnect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowMore information about Lipedemahttps://www.lipedema.org/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652358/https://www.fatdisorders.org/

Dr. Carol is double Board-Certified in Family Medicine and Obesity Medicine as well as a Master movement, meditation, and mindset coach who brings more than 40 years of experience and expertise in Mind-Body Medicine and the movement sciences.  Questions this episode will answer: What are some ways to change healthcare and healthcare education to be more holistic? What is the Gambia Collaborative Project? What are some mindset tips and strategies to help you follow your passion and purpose? Whether you are in medicine, interested in meditation and mindset, or are simply interested in how you can get to a better life, there is something for you in this episode. Find Dr. Carol: Penn: www.drcarolpenn.com www.penngmg.com Resources: Get your free Better Mental Health Affirmations: Affirmationbonus.com About Dr. Carol Penn: Dr. Carol A. Penn, DO, MA, ABOM, FACOFP doubly Board Certified in Family Medicine and Obesity Medicine as well as being a Master movement, meditation, and mindset coach brings more than 40 years of experience and expertise in Mind-Body Medicine and the movement sciences. Gifted with the ability to inspire and educate about self-care, Dr. Penn brings a unique set of skills to her work as a physician.  Her work in Mindful Movement and the dynamic small group facilitation work in the Mind Body Spirit Medicine series is designed to assist each participant in their journey of deep self-care and in learning how to prioritize themselves on behalf of achieving their best and highest self.  She is a super proud wife, mom, and daughter living and loving in the midst of a beautiful blended family, surrounded by a beloved extended family and connections and kinship with friends and colleagues.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/XCX865. CME/AAPA credit will be available until November 26, 2024.Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People With T2DM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJavier Morales, MD, FACP, FACE, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Speaker for Amgen Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Co-Chair/PlannerJay H. Shubrook, DO, FAAFP, FACOFP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abbott; AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Lilly; Nevro Corp.; and Novo Nordisk Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/XCX865. CME/AAPA credit will be available until November 26, 2024.Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People With T2DM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJavier Morales, MD, FACP, FACE, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Speaker for Amgen Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Co-Chair/PlannerJay H. Shubrook, DO, FAAFP, FACOFP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abbott; AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Lilly; Nevro Corp.; and Novo Nordisk Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/XCX865. CME/AAPA credit will be available until November 26, 2024.Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People With T2DM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJavier Morales, MD, FACP, FACE, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Speaker for Amgen Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Co-Chair/PlannerJay H. Shubrook, DO, FAAFP, FACOFP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abbott; AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Lilly; Nevro Corp.; and Novo Nordisk Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/XCX865. CME/AAPA credit will be available until November 26, 2024.Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People With T2DM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJavier Morales, MD, FACP, FACE, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Speaker for Amgen Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Co-Chair/PlannerJay H. Shubrook, DO, FAAFP, FACOFP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abbott; AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Lilly; Nevro Corp.; and Novo Nordisk Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/XCX865. CME/AAPA credit will be available until November 26, 2024.Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People With T2DM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJavier Morales, MD, FACP, FACE, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Speaker for Amgen Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Co-Chair/PlannerJay H. Shubrook, DO, FAAFP, FACOFP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abbott; AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Lilly; Nevro Corp.; and Novo Nordisk Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/XCX865. CME/AAPA credit will be available until November 26, 2024.Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People With T2DM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJavier Morales, MD, FACP, FACE, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Speaker for Amgen Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Co-Chair/PlannerJay H. Shubrook, DO, FAAFP, FACOFP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abbott; AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Lilly; Nevro Corp.; and Novo Nordisk Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/XCX865. CME/AAPA credit will be available until November 26, 2024.Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People With T2DM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJavier Morales, MD, FACP, FACE, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Speaker for Amgen Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Co-Chair/PlannerJay H. Shubrook, DO, FAAFP, FACOFP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abbott; AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Lilly; Nevro Corp.; and Novo Nordisk Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/XCX865. CME/AAPA credit will be available until November 26, 2024.Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People With T2DM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJavier Morales, MD, FACP, FACE, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Speaker for Amgen Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; and Novo Nordisk Inc.Co-Chair/PlannerJay H. Shubrook, DO, FAAFP, FACOFP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abbott; AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Lilly; Nevro Corp.; and Novo Nordisk Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

Go online to PeerView.com/PQU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Type 2 diabetes (T2D) is a progressive disease that is largely preventable and entirely treatable. Timely intensification of therapy is a foundational principle of contemporary management of people with T2D since this strategy is associated with better long-term health outcomes. In conjunction with intensified therapy, modest weight loss has been shown to improve overall and long-term health outcomes. In this activity, based on a series of Project ECHO® workshops and produced in collaboration with the American College of Diabetology, you'll learn best practices for individualizing patient care and intensifying therapy with evidence-based pharmacologic management of T2D with non-insulin glucose-lowering therapies. Now is the time! Watch today to begin adding these practical strategies to your toolbox! Upon completion of this activity, participants should be better able to: Intensify treatment in people with T2D consistent with the latest guidelines, available evidence, and shared decision-making principles to control glycemia and weight to optimize outcomes and avoid long-term complications; Explain the rationale for targeting weight and establish personalized weight loss goals as a treatment priority for comprehensive T2D management; and Counsel people with T2D about the relationship between obesity and diabetes and the importance of achieving and maintaining a healthy weight as a T2D treatment priority.

Go online to PeerView.com/PQU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Type 2 diabetes (T2D) is a progressive disease that is largely preventable and entirely treatable. Timely intensification of therapy is a foundational principle of contemporary management of people with T2D since this strategy is associated with better long-term health outcomes. In conjunction with intensified therapy, modest weight loss has been shown to improve overall and long-term health outcomes. In this activity, based on a series of Project ECHO® workshops and produced in collaboration with the American College of Diabetology, you'll learn best practices for individualizing patient care and intensifying therapy with evidence-based pharmacologic management of T2D with non-insulin glucose-lowering therapies. Now is the time! Watch today to begin adding these practical strategies to your toolbox! Upon completion of this activity, participants should be better able to: Intensify treatment in people with T2D consistent with the latest guidelines, available evidence, and shared decision-making principles to control glycemia and weight to optimize outcomes and avoid long-term complications; Explain the rationale for targeting weight and establish personalized weight loss goals as a treatment priority for comprehensive T2D management; and Counsel people with T2D about the relationship between obesity and diabetes and the importance of achieving and maintaining a healthy weight as a T2D treatment priority.

Go online to PeerView.com/PQU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Type 2 diabetes (T2D) is a progressive disease that is largely preventable and entirely treatable. Timely intensification of therapy is a foundational principle of contemporary management of people with T2D since this strategy is associated with better long-term health outcomes. In conjunction with intensified therapy, modest weight loss has been shown to improve overall and long-term health outcomes. In this activity, based on a series of Project ECHO® workshops and produced in collaboration with the American College of Diabetology, you'll learn best practices for individualizing patient care and intensifying therapy with evidence-based pharmacologic management of T2D with non-insulin glucose-lowering therapies. Now is the time! Watch today to begin adding these practical strategies to your toolbox! Upon completion of this activity, participants should be better able to: Intensify treatment in people with T2D consistent with the latest guidelines, available evidence, and shared decision-making principles to control glycemia and weight to optimize outcomes and avoid long-term complications; Explain the rationale for targeting weight and establish personalized weight loss goals as a treatment priority for comprehensive T2D management; and Counsel people with T2D about the relationship between obesity and diabetes and the importance of achieving and maintaining a healthy weight as a T2D treatment priority.

Go online to PeerView.com/PQU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Type 2 diabetes (T2D) is a progressive disease that is largely preventable and entirely treatable. Timely intensification of therapy is a foundational principle of contemporary management of people with T2D since this strategy is associated with better long-term health outcomes. In conjunction with intensified therapy, modest weight loss has been shown to improve overall and long-term health outcomes. In this activity, based on a series of Project ECHO® workshops and produced in collaboration with the American College of Diabetology, you'll learn best practices for individualizing patient care and intensifying therapy with evidence-based pharmacologic management of T2D with non-insulin glucose-lowering therapies. Now is the time! Watch today to begin adding these practical strategies to your toolbox! Upon completion of this activity, participants should be better able to: Intensify treatment in people with T2D consistent with the latest guidelines, available evidence, and shared decision-making principles to control glycemia and weight to optimize outcomes and avoid long-term complications; Explain the rationale for targeting weight and establish personalized weight loss goals as a treatment priority for comprehensive T2D management; and Counsel people with T2D about the relationship between obesity and diabetes and the importance of achieving and maintaining a healthy weight as a T2D treatment priority.

Go online to PeerView.com/PQU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Type 2 diabetes (T2D) is a progressive disease that is largely preventable and entirely treatable. Timely intensification of therapy is a foundational principle of contemporary management of people with T2D since this strategy is associated with better long-term health outcomes. In conjunction with intensified therapy, modest weight loss has been shown to improve overall and long-term health outcomes. In this activity, based on a series of Project ECHO® workshops and produced in collaboration with the American College of Diabetology, you'll learn best practices for individualizing patient care and intensifying therapy with evidence-based pharmacologic management of T2D with non-insulin glucose-lowering therapies. Now is the time! Watch today to begin adding these practical strategies to your toolbox! Upon completion of this activity, participants should be better able to: Intensify treatment in people with T2D consistent with the latest guidelines, available evidence, and shared decision-making principles to control glycemia and weight to optimize outcomes and avoid long-term complications; Explain the rationale for targeting weight and establish personalized weight loss goals as a treatment priority for comprehensive T2D management; and Counsel people with T2D about the relationship between obesity and diabetes and the importance of achieving and maintaining a healthy weight as a T2D treatment priority.

Go online to PeerView.com/PQU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Type 2 diabetes (T2D) is a progressive disease that is largely preventable and entirely treatable. Timely intensification of therapy is a foundational principle of contemporary management of people with T2D since this strategy is associated with better long-term health outcomes. In conjunction with intensified therapy, modest weight loss has been shown to improve overall and long-term health outcomes. In this activity, based on a series of Project ECHO® workshops and produced in collaboration with the American College of Diabetology, you'll learn best practices for individualizing patient care and intensifying therapy with evidence-based pharmacologic management of T2D with non-insulin glucose-lowering therapies. Now is the time! Watch today to begin adding these practical strategies to your toolbox! Upon completion of this activity, participants should be better able to: Intensify treatment in people with T2D consistent with the latest guidelines, available evidence, and shared decision-making principles to control glycemia and weight to optimize outcomes and avoid long-term complications; Explain the rationale for targeting weight and establish personalized weight loss goals as a treatment priority for comprehensive T2D management; and Counsel people with T2D about the relationship between obesity and diabetes and the importance of achieving and maintaining a healthy weight as a T2D treatment priority.

Go online to PeerView.com/PQU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Type 2 diabetes (T2D) is a progressive disease that is largely preventable and entirely treatable. Timely intensification of therapy is a foundational principle of contemporary management of people with T2D since this strategy is associated with better long-term health outcomes. In conjunction with intensified therapy, modest weight loss has been shown to improve overall and long-term health outcomes. In this activity, based on a series of Project ECHO® workshops and produced in collaboration with the American College of Diabetology, you'll learn best practices for individualizing patient care and intensifying therapy with evidence-based pharmacologic management of T2D with non-insulin glucose-lowering therapies. Now is the time! Watch today to begin adding these practical strategies to your toolbox! Upon completion of this activity, participants should be better able to: Intensify treatment in people with T2D consistent with the latest guidelines, available evidence, and shared decision-making principles to control glycemia and weight to optimize outcomes and avoid long-term complications; Explain the rationale for targeting weight and establish personalized weight loss goals as a treatment priority for comprehensive T2D management; and Counsel people with T2D about the relationship between obesity and diabetes and the importance of achieving and maintaining a healthy weight as a T2D treatment priority.

Go online to PeerView.com/PQU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Type 2 diabetes (T2D) is a progressive disease that is largely preventable and entirely treatable. Timely intensification of therapy is a foundational principle of contemporary management of people with T2D since this strategy is associated with better long-term health outcomes. In conjunction with intensified therapy, modest weight loss has been shown to improve overall and long-term health outcomes. In this activity, based on a series of Project ECHO® workshops and produced in collaboration with the American College of Diabetology, you'll learn best practices for individualizing patient care and intensifying therapy with evidence-based pharmacologic management of T2D with non-insulin glucose-lowering therapies. Now is the time! Watch today to begin adding these practical strategies to your toolbox! Upon completion of this activity, participants should be better able to: Intensify treatment in people with T2D consistent with the latest guidelines, available evidence, and shared decision-making principles to control glycemia and weight to optimize outcomes and avoid long-term complications; Explain the rationale for targeting weight and establish personalized weight loss goals as a treatment priority for comprehensive T2D management; and Counsel people with T2D about the relationship between obesity and diabetes and the importance of achieving and maintaining a healthy weight as a T2D treatment priority.

Barbara Walker, DO, FACOFP, talks about the role of medical boards vs medical federations, solutions for professionals lapses, how to avoid boundary issue lapses, social media issues, how lapses have changed over the years, the importance of self-care, her expectations of what should be taught, and resources with Barbara Lewis, MBA.

Dr. Rob Kominiarek D.O., FACOFP is a board-certified Fellow of the American College of Osteopathic Family Physicians and a Fellows Crest Award Winner with advanced training in Age Management Medicine and Hormone Optimization. He is president of ReNue Health®. Dr. Rob is a graduate of Nova-Southeastern University, College of Osteopathic Medicine in Fort Lauderdale, Florida. He completed his residency training at Ohio University, Grandview Hospital and Medical Center in Dayton, Ohio and is an Assistant Clinical Professor at Ohio University. Dr. Rob is a veteran of the United States Army and is an Amazon bestselling author with a passion directed towards overall health of the mind and body through proper nutritional habits, regular exercise, appropriate supplementation, and the intelligent optimization of hormones.In this episode we discuss:The future of the healthcare industry.Is testosterone replacement therapy for you?Why strength training is better than endurance training for longevity.The real science behind optimizing your hormones.This episode is brought to you by One Farm, Cozy Earth, Inside Tracker, 1stPhormFollow Rob on IG Order Dr. Lyon's Book Forever Strong - https://drgabriellelyon.com/forever-strong/Mentioned in this episode:Save 35% on your orderhttp://CozyEarth.com/DRLYONFREE Gut Health Superfood with code LYONGHhttps://onefarm.com/Visit 1st Phorm Website for Free Shippinghttp://www.1stphorm.com/drlyonInside Tracker 20% Off the Entire Storehttps://info.insidetracker.com/drlyon

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings and Dr. Andreas Acosta discuss the importance of aligning appropriate lifestyle interventions to each of the four key phenotypes that explain about eighty-five percent of patients with obesity. Andreas Acosta, MD, PhD is an assistant professor in the Division of Gastroenterology and Hepatology at the Mayo Clinic in Rochester, MN. Dr. Acosta presented his exciting research at the OMA Fall 2022 Obesity Summit in Anaheim, CA, in a presentation titled “Phenotype-Guided Lifestyle Intervention for Obesity Management" Topics discussed include hungry gut, emotional eater, and slow metabolizer phenotypes. Additional topics include overlapping phenotypes, phenotype profiling, and treatment approaches. Episode Guests Andreas Acosta, MD, PhD Nicholas Pennings, DO, FOMA, FACOFP

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Nicholas Pennings, DO, FOMA, FACOFP, and John Jakicic, PhD, discuss the importance of physical activity in weight management and overall health. Dr. John Jakicic is a Research Professor in the Department of Internal Medicine in the Division of Physical Activity and Weight Management at the University of Kansas. Dr. Jakicic presented at the OMA Fall 2022 Obesity Summit in Anaheim, CA. His talk was titled “Weight a Minute: Considerations for Physical Activity Being Effective for Weight Loss and Maintenance”. Topics discussed include the expectations of the benefits of exercise, the role of physical activity in obesity treatment, pairing dietary recommendations with physical activity plans, and adaptive mechanisms. Episode Guests Nicholas Pennings, DO, FOMA, FACOFP John Jakicic, PhD

Lori Kemper, DO, MS, FACOFP, Dean of the Midwestern University Arizona College of Osteopathic Medicine, discusses graduate medical education. Dr. Kemper joined the faculty of Midwestern University after 25 years of practicing family medicine in Chandler and Tempe, Arizona. She enjoys working with patients of all ages. Dr. Kemper has served as Dean of the Arizona College of Osteopathic Medicine since 2007. The Arizona Physician Podcast is published by the Maricopa County Medical Society. Hosted by John McElligott. Music by Blue Dot Sessions.

The last 2.5 years pushed the world to the brink, and one of the biggest downstream effects is many people completely losing their way when it comes to their health and wellness.   On top of us already being in such a contaminated environment, people are experiencing health issues due to neglecting the basics. Now more than ever, we have to recommit to the pillars of wellness and make sure the fundamentals are in check.   What are some of the things we need to be fine tuning and getting back on track? In this episode, the medical director of ReNue Health®, Dr. Rob Kominiarek returns to share the health issue so many people are struggling with at the moment, and the latest and greatest in optimization to get back on track.   Study after study has shown that if there's one thing you want to do to reverse insulin resistance, change your weight and body shape besides exercise, it's getting good sleep. -Dr. Rob Kominiarek   Three Things We Learned    How to keep your mind and soul healthyWhy is it so important to have some sort of restorative practice in place right now? The key to being optimizedWhat does taking care of yourself look like in the age of the bioweapon? How to remove poison from your existenceEliminating toxicity isn't just about what we eat or drink, what are the other areas of our lives we need to pay attention to?    Guest Bio Dr. Rob Kominiarek D.O., FACOFP is a board certified Fellow of the American College of Osteopathic Family Physicians with advanced certification in Age Management Medicine and BioIdentical Hormone Replacement Therapy. He is medical director of ReNue Health®. Dr. Rob is a graduate of Nova-Southeastern University, College of Osteopathic Medicine in Fort Lauderdale, Florida. He completed his residency training at Ohio University, Grandview Hospital and Medical Center in Dayton, Ohio. He is a medical advisor and director to emergency medical services, police departments and radio and television shows across the country. You can watch Dr. Rob on his weekly health segment “Dr. Rob In The House” on Living Dayton, WDTN2 every wednesday at noon. Dr. Rob is a veteran of the United States Army and is a bestselling author with a passion directed towards overall health of the mind and body through proper eating habits, regular exercise, appropriate supplementation, and the intelligent optimization of hormones when clinically indicated. For more information about working with Dr. Rob, head to https://www.renuehealth.com/.

Go online to PeerView.com/ACR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses how to utilize the American Gastroenterological Association's Clinical Care Pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Upon completion of this activity, participants should be better able to: List the disease pathways and mechanisms that define NASH as a metabolic disease; Identify the pathophysiology and role of GLP-1 as a therapeutic target in NASH; Differentially diagnose NASH in a timely manner; Integrate current and emerging agents into early management plans for patients with NASH based on the AGA NASH Clinical Care Pathway

Go online to PeerView.com/ACR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses how to utilize the American Gastroenterological Association's Clinical Care Pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Upon completion of this activity, participants should be better able to: List the disease pathways and mechanisms that define NASH as a metabolic disease; Identify the pathophysiology and role of GLP-1 as a therapeutic target in NASH; Differentially diagnose NASH in a timely manner; Integrate current and emerging agents into early management plans for patients with NASH based on the AGA NASH Clinical Care Pathway

Go online to PeerView.com/ACR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses how to utilize the American Gastroenterological Association's Clinical Care Pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Upon completion of this activity, participants should be better able to: List the disease pathways and mechanisms that define NASH as a metabolic disease; Identify the pathophysiology and role of GLP-1 as a therapeutic target in NASH; Differentially diagnose NASH in a timely manner; Integrate current and emerging agents into early management plans for patients with NASH based on the AGA NASH Clinical Care Pathway

Go online to PeerView.com/ACR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses how to utilize the American Gastroenterological Association's Clinical Care Pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Upon completion of this activity, participants should be better able to: List the disease pathways and mechanisms that define NASH as a metabolic disease; Identify the pathophysiology and role of GLP-1 as a therapeutic target in NASH; Differentially diagnose NASH in a timely manner; Integrate current and emerging agents into early management plans for patients with NASH based on the AGA NASH Clinical Care Pathway

Go online to PeerView.com/ACR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses how to utilize the American Gastroenterological Association's Clinical Care Pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Upon completion of this activity, participants should be better able to: List the disease pathways and mechanisms that define NASH as a metabolic disease; Identify the pathophysiology and role of GLP-1 as a therapeutic target in NASH; Differentially diagnose NASH in a timely manner; Integrate current and emerging agents into early management plans for patients with NASH based on the AGA NASH Clinical Care Pathway

Go online to PeerView.com/ACR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses how to utilize the American Gastroenterological Association's Clinical Care Pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Upon completion of this activity, participants should be better able to: List the disease pathways and mechanisms that define NASH as a metabolic disease; Identify the pathophysiology and role of GLP-1 as a therapeutic target in NASH; Differentially diagnose NASH in a timely manner; Integrate current and emerging agents into early management plans for patients with NASH based on the AGA NASH Clinical Care Pathway

Go online to PeerView.com/ACR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses how to utilize the American Gastroenterological Association's Clinical Care Pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Upon completion of this activity, participants should be better able to: List the disease pathways and mechanisms that define NASH as a metabolic disease; Identify the pathophysiology and role of GLP-1 as a therapeutic target in NASH; Differentially diagnose NASH in a timely manner; Integrate current and emerging agents into early management plans for patients with NASH based on the AGA NASH Clinical Care Pathway

Go online to PeerView.com/ACR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses how to utilize the American Gastroenterological Association's Clinical Care Pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Upon completion of this activity, participants should be better able to: List the disease pathways and mechanisms that define NASH as a metabolic disease; Identify the pathophysiology and role of GLP-1 as a therapeutic target in NASH; Differentially diagnose NASH in a timely manner; Integrate current and emerging agents into early management plans for patients with NASH based on the AGA NASH Clinical Care Pathway

Go online to PeerView.com/ACR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses how to utilize the American Gastroenterological Association's Clinical Care Pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Upon completion of this activity, participants should be better able to: List the disease pathways and mechanisms that define NASH as a metabolic disease; Identify the pathophysiology and role of GLP-1 as a therapeutic target in NASH; Differentially diagnose NASH in a timely manner; Integrate current and emerging agents into early management plans for patients with NASH based on the AGA NASH Clinical Care Pathway

Go online to PeerView.com/ACR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses how to utilize the American Gastroenterological Association's Clinical Care Pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Upon completion of this activity, participants should be better able to: List the disease pathways and mechanisms that define NASH as a metabolic disease; Identify the pathophysiology and role of GLP-1 as a therapeutic target in NASH; Differentially diagnose NASH in a timely manner; Integrate current and emerging agents into early management plans for patients with NASH based on the AGA NASH Clinical Care Pathway

Wound Care | On Call with the Prairie Doc® | Oct. 28, 2021 | Prairie Doc® host Dr. Jill Kruse is joined by Katherine Lincoln, DO, MHA, FACOFP, FAAFP, Guthrie Medical Group, Sayre, PA, and Nephi Jones, DPM, Avera Orthopedics, Brookings. They answer viewer questions about the importance of proper wound care and various treatments.

Dr. Joseph De Gaetano, DO, MSEd, FAAFP, FACOFP is a family medicine physician who is a faculty member at Broward Health Family Residency Program and Nova Southeastern University College of Osteopathic Medicine. — Hosts: Daniel Epstein & Raj Kavadi Producer: Timothy Crowe Social Media Director: Anja Von Der Osten Music: Foximusic.com

We continue discussing hormones.  This time we will discuss TRT for men.  My guest is Dr. Rob Kominiarek D.O., FACOFP who is a board certified, Fellow of the American College of Osteopathic Family Physicians with advanced certification in Age Management Medicine and Bio-Identical Hormone Replacement Therapy. He is medical director of ReNue Health®. Dr. Rob is a graduate of the Nova-Southeastern University, College of Osteopathic Medicine in Fort Lauderdale, Florida. He completed his residency training at Ohio University, Grandview Hospital and Medical Center in Dayton, Ohio. He is a medical advisor and director to emergency medical services, police departments and radio and television shows across the country. You can watch Dr. Rob on his weekly health segment “Dr. Rob In The House” on Living Dayton, WDTN2 every wednesday at noon. Dr. Rob is a veteran of the United States Army and is a bestselling author with a passion directed towards overall health of the mind and body thru proper eating habits, regular exercise, appropriate supplementation, and the intelligent optimization of hormones when clinically indicated.

Go online to PeerView.com/PVT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in type 2 diabetes (T2DM) management discusses how to individualize treatment with GLP-1 RAs to improve outcomes for patients. Upon completion of this activity, participants should be better able to: Apply evidence-based treatment recommendations for GLP-1 RAs based on clinical trial results evaluating glycemic and extra-glycemic (eg, cardiovascular risk reduction, weight education) outcomes in patients with T2DM, Identify potential barriers to use (ie, mode of administration, adverse events) for current and emerging GLP-1 RAs, Engage in patient-centered discussions about the benefits and risks of using GLP-1 RAs to personalize management of T2DM.

Go online to PeerView.com/PVT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in type 2 diabetes (T2DM) management discusses how to individualize treatment with GLP-1 RAs to improve outcomes for patients. Upon completion of this activity, participants should be better able to: Apply evidence-based treatment recommendations for GLP-1 RAs based on clinical trial results evaluating glycemic and extra-glycemic (eg, cardiovascular risk reduction, weight education) outcomes in patients with T2DM, Identify potential barriers to use (ie, mode of administration, adverse events) for current and emerging GLP-1 RAs, Engage in patient-centered discussions about the benefits and risks of using GLP-1 RAs to personalize management of T2DM.

Go online to PeerView.com/PVT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in type 2 diabetes (T2DM) management discusses how to individualize treatment with GLP-1 RAs to improve outcomes for patients. Upon completion of this activity, participants should be better able to: Apply evidence-based treatment recommendations for GLP-1 RAs based on clinical trial results evaluating glycemic and extra-glycemic (eg, cardiovascular risk reduction, weight education) outcomes in patients with T2DM, Identify potential barriers to use (ie, mode of administration, adverse events) for current and emerging GLP-1 RAs, Engage in patient-centered discussions about the benefits and risks of using GLP-1 RAs to personalize management of T2DM.

Go online to PeerView.com/PVT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in type 2 diabetes (T2DM) management discusses how to individualize treatment with GLP-1 RAs to improve outcomes for patients. Upon completion of this activity, participants should be better able to: Apply evidence-based treatment recommendations for GLP-1 RAs based on clinical trial results evaluating glycemic and extra-glycemic (eg, cardiovascular risk reduction, weight education) outcomes in patients with T2DM, Identify potential barriers to use (ie, mode of administration, adverse events) for current and emerging GLP-1 RAs, Engage in patient-centered discussions about the benefits and risks of using GLP-1 RAs to personalize management of T2DM.

Go online to PeerView.com/PVT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in type 2 diabetes (T2DM) management discusses how to individualize treatment with GLP-1 RAs to improve outcomes for patients. Upon completion of this activity, participants should be better able to: Apply evidence-based treatment recommendations for GLP-1 RAs based on clinical trial results evaluating glycemic and extra-glycemic (eg, cardiovascular risk reduction, weight education) outcomes in patients with T2DM, Identify potential barriers to use (ie, mode of administration, adverse events) for current and emerging GLP-1 RAs, Engage in patient-centered discussions about the benefits and risks of using GLP-1 RAs to personalize management of T2DM.

Go online to PeerView.com/PVT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in type 2 diabetes (T2DM) management discusses how to individualize treatment with GLP-1 RAs to improve outcomes for patients. Upon completion of this activity, participants should be better able to: Apply evidence-based treatment recommendations for GLP-1 RAs based on clinical trial results evaluating glycemic and extra-glycemic (eg, cardiovascular risk reduction, weight education) outcomes in patients with T2DM, Identify potential barriers to use (ie, mode of administration, adverse events) for current and emerging GLP-1 RAs, Engage in patient-centered discussions about the benefits and risks of using GLP-1 RAs to personalize management of T2DM.

Go online to PeerView.com/PVT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in type 2 diabetes (T2DM) management discusses how to individualize treatment with GLP-1 RAs to improve outcomes for patients. Upon completion of this activity, participants should be better able to: Apply evidence-based treatment recommendations for GLP-1 RAs based on clinical trial results evaluating glycemic and extra-glycemic (eg, cardiovascular risk reduction, weight education) outcomes in patients with T2DM, Identify potential barriers to use (ie, mode of administration, adverse events) for current and emerging GLP-1 RAs, Engage in patient-centered discussions about the benefits and risks of using GLP-1 RAs to personalize management of T2DM.

Go online to PeerView.com/PVT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in type 2 diabetes (T2DM) management discusses how to individualize treatment with GLP-1 RAs to improve outcomes for patients. Upon completion of this activity, participants should be better able to: Apply evidence-based treatment recommendations for GLP-1 RAs based on clinical trial results evaluating glycemic and extra-glycemic (eg, cardiovascular risk reduction, weight education) outcomes in patients with T2DM, Identify potential barriers to use (ie, mode of administration, adverse events) for current and emerging GLP-1 RAs, Engage in patient-centered discussions about the benefits and risks of using GLP-1 RAs to personalize management of T2DM.

My guest, Dr. Carol A. Penn, DO, MA, ABOM, FACOFP doubly Board Certified in Family Medicine and Obesity Medicine and being a Master movement, meditation, and mindset coach bring more than 40 years of experience and expertise in Mind-Body Medicine and the movement sciences. Gifted with the ability to inspire and educate about self-care, Dr. Penn brings a unique set of skills to her work as a physician. Her work in Mindful Movement and the dynamic small group facilitation work in the Mind Body Spirit Medicine series is designed to assist each participant in their journey of deep self-care and in learning how to prioritize themselves on behalf of achieving their best and highest self. A business-woman, servant leader, and entrepreneur, Dr. Penn is a Founder/Activist and Chief Visionary Officer of Penn Global Visions LLC, a health and education multi-media firm changing the world one meditation at a time. In this episode, we discuss: The journey for Dr. Carol from Alvin Ailey dancer to physician leader in psychiatry and now incorporating meditation and mindset mastery coaching for professionals.  What was the most difficult part of her journey? What are some ways in which women physicians can begin to develop a mindset for leading? 3 tips she shares with women physicians about showing up with confidence in the workplace as a leader? Follow Dr. Carol www.drcarolpenn.com email info@drcarolpenn On all social media @drcarolpenn Work with Dr. Lisa, Physician Leadership Coach If you're ready to transition into a leadership role or need support in your current role as a leader, schedule your free leadership consulting call at schedulewithdrlisa.com  

Dr. Carol A. Penn, DO, MA, ABOM, FACOFP doubly Board Certified in Family Medicine and Obesity Medicine as well as being a Master movement, meditation, and mindset coach brings more than 40 years of experience and expertise in Mind Body Medicine and the movement sciences. Gifted with the ability to inspire and educate about self care, Dr. Penn brings a unique set of skills to her work as a physician. Her work in Mindful Movement and the dynamic small group facilitation work in the Mind Body Spirit Medicine series is designed to assist each participant in their journey of deep self care and in learning how to prioritize themselves on behalf of achieving their best and highest self. In her online Mind Body Medicine series you will learn how to balance your Sympathetic and Parasympathetic nervous system as well as how to uncouple the amygdala and hippocampus regions of the brain from fear based behaviors that hold us back and keep us stuck.Dr. Penn hoping to guide each person on their own unique journey, holds national certifications in Mind Body Medicine from the Center for Mind Body Medicine; Health, Wellness and Fitness Coach from Wellcoaches; and is a certified Personal Trainer from the National Council on Strength and Fitness. Additionally, she has a 500 hour certification in yoga from Soma Yoga and is certified in Organ Cleansing QiGong. She also brings her artistic sensibilities to the marriage of the arts and medicine with her background as a professionally trained dancer and choreographer with the world famous Alvin Ailey American Dance Theater and a Kennedy Center for the Performing Arts Teaching Fellow, Dr. Penn will get you moving and keep you moving on your path to health and wellness.Having achieved a rare standard of excellence in the Academic community, Dr. Penn is a Fellow in the American Academy of Osteopathic Family Physicians and is Clinical Faculty with Rowan University School of Osteopathic Medicine, the Center for Mind Body Medicine, and the Medical Moguls Academy. She is a recent graduate of the Whole Health Medical Institute and serves as a leader in her community as a member of the Board of Health and in her capacity as a Trustee with Lunch Break Inc. She is also a two time best selling author and her book: Meditation In a Time of Madness, launched in 2019 as a number 1 best seller in the category of meditation and alternative medicine.A business woman, servant leader and entrepreneur, Dr. Penn is a Founder/Activist and Chief Visionary Officer of Penn Global Visions LLC, a health and education multi-media firm changing the world one meditation at a time. Soon the doors to Penn Mogul Medical Group, her concierge medical practice will be open! She is a medical correspondent for WURD Radio in Philadelphia where she is a frequent guest and Podcastor as well as the host of her own weekly show and podcast: Weightless in Mind, Body and Spirit. A creative forever, she continues to direct her all volunteer women’s dance ensemble Core of Fire.Follow Knowledgeable Aging:Facebook: https://www.facebook.com/Knowledgeable-Aging-102638398162823Twitter: https://twitter.com/KnowledgeAgingInstagram: https://www.instagram.com/knowledgeableaging/LinkedIn: https://www.linkedin.com/company/knowledgeable-aging/?viewAsMember=trueSpotify: https://open.spotify.com/show/05OHF9FkmhzCO5PDsyGfGqNewsletter: https://www.knowledgeableaging.com/newsletter/

On todays show I have Dr. Becca Rodriguez a Sports Medicine MD. She is one of the top MDs in the nation around sports medicine. She has been the American Osteopathic Academy of Sports Medicine Member of the month. Dr. Rodriguez is th ephysician for the USOC Olympic Training Center, Team USA Women's Waterpolo, Team USA Rugby Mends, SD Legion Major League Rugby, and San Diego Ballet. On todays show we will be talking about CTE. The signs, symptoms and protocols that you need to do if you do have a concussion. Hope this episode helps. More about Dr. Becca Rodriguez: Board-certified in Family Medicine and Sports Medicine, Rebeccah Rodríguez, DO, FACOFP, serves the communities of Encinitas, San Diego, and Temecula, California, at OasisMD. Dr. Rodríguez earned her medical degree from Kirksville College of Osteopathic Medicine. She serves the United States Olympic & Paralympic Committee (USOPC) as a Team USA physician and was on the medical staff at the Olympic Training Site in Chula Vista, California, as team physician for 10 years. Dr. Rodriguez served as the Medical Director for the high-performance center for Team USA (11 sports) at the 2016 Olympics in Rio. She was part of the medical staff as Team USA physician at the 2019 Pan American Games in Lima, Peru. She is honored to currently serve on the USOPC Physician Advisory Board. Dr. Rodriguez is also a team physician for USA Women's Waterpolo and USA Rugby. She is the head team physician for the major league rugby team, the San Diego Legion. Passionate about improving quality healthcare, Dr. Rodriguez helps make policy for national organizations such as the AOASM as second Vice President, ACOFP California Board, ACOFP Health and Wellness and Procedural Committee, and the President's Council for Sports, Fitness, and Nutrition. She travels the world with Team USA and loves to be active with sports and spend time with her husband and son. If you want to contact Dr. Rodriguez you can reach her at: OasisMD Lifestyle Healthcare, Encinitas, CA Phone (appointments): 844-627-4763 | Phone (general inquiries): 844-627-4763 Address: 499 N El Camino Real, Suite C-200, Encinitas, CA 92024 OasisMD Lifestyle Healthcare, Temecula, CA Phone (appointments): 844-627-4763 | Phone (general inquiries): 844-627-4763 Address: 27699 Jefferson Avenue, Suite 201, Temecula, CA 92590 Connect with me: https://linktr.ee/TheSegment

Overview: FAQ for Cases in Treating Chronic Pain: Best Approaches to Management (Not for CME)   Guest: Katherine E. Galluzzi, DO, CMD, FACOFP